Savita Nikam

Dr. Nikam has more than 20 years of research experience in academia and with biotechnology companies. Her expertise includes molecular biology, protein biochemistry, and expression of products from mammalian, yeast, and bacterial expression systems. Dr. Nikam gained extensive experience in molecular imaging research at Charles River Co, manipulating different cancer cell lines and generating reporter models for in vivo imaging of apoptosis following new cancer drug treatment. Her research included the development of a potent viral vaccine against Japanese encephalitis from primary chick embryo cell cultures. Dr. Nikham received her Ph.D. in microbiology from the National Institute of Virology, Pune University, India. She completed her post-doctoral research on the mechanism of HIV reverse transcriptase fidelity and the kinetic basis of drug resistance at the University of Michigan.